Increlex

In the US, INCRELEX (mecasermin systemic) is a member of the drug class insulin-like growth factor and is used to treat Primary IGF-1 Deficiency.

US matches:

• Increlex

UK matches:

• Increlex 10mg/mL solution for injection
• Increlex 10mg/ml solution for injection (SPC)

Ingredient matches for INCRELEX

Mecasermin

Mecasermin is reported as an ingredient of INCRELEX in the following countries:

• Austria


• Belgium


• Denmark


• France


• Germany


• Greece


• Ireland


• Italy


• Netherlands


• Spain


• Sweden


• United Kingdom

Mecasermin rinfabate (a derivative of Mecasermin) is reported as an ingredient of INCRELEX in the following countries:

• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.